hepatitis C virus (HCV) FibroSURE
Jump to navigation
Jump to search
Indications
- assessment of Liver status following a diagnosis of hepatitis C virus (HCV)
- baseline determination of liver status before initiating hepatitis C virus (HCV) therapy
- post-treatment assessment of liver status six months after completion of hepatitis C virus (HCV) therapy
- non-invasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy
Procedure
- alpha-2-Macroglobulin in serum
- haptoglobin in serum
- apolipoprotein A1 in serum
- bilirubin total in serum
- gamma-glutamyltransferase in serum
- alanine aminotransferase in serum
Interpretation
- a fibrosis score is calculated
More general terms
Additional terms
References
- ↑ Hepatitis C Virus (HCV) FibroSURE http://www.mayomedicallaboratories.com/test-catalog/Overview/91402